KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Non-Current Deferred Tax Liability (2021 - 2026)

Castle Biosciences' Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $33.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 35.84% to $33.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.0 million, a 35.84% increase, with the full-year FY2025 number at $33.0 million, up 35.84% from a year prior.
  • Non-Current Deferred Tax Liability hit $33.0 million in Q4 2025 for Castle Biosciences, up from $3.2 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for CSTL hit a ceiling of $33.0 million in Q4 2025 and a floor of $206000.0 in Q4 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $6.3 million across 5 years, with a median of $696000.0 in 2021.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 99.24% in 2023 and later soared 11690.29% in 2024.
  • Tracing CSTL's Non-Current Deferred Tax Liability over 5 years: stood at $635000.0 in 2021, then skyrocketed by 4170.39% to $27.1 million in 2022, then crashed by 99.24% to $206000.0 in 2023, then soared by 11690.29% to $24.3 million in 2024, then soared by 35.84% to $33.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for CSTL at $33.0 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.